BCL2L1 and cancer: Altogether, these results indicate that paclitaxel treatment recruits cGAS/STING activation in response to unstable nuclear membrane of induced micronuclei and that this induces a secretory phenotype which promotes BCL-xL-dependent apoptotic priming in untreated cancer cells.